Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 5:00 pm Purchase | 2026-03-31 | 13G | BIOGEN INC BIIB | Vanguard Capital Management | 10,989,562 7.480% | 10,989,562 (New Position) | Filing History |
| 2026-04-06 6:08 pm Purchase | 2026-03-31 | 13D | APELLIS PHARMACEUTICALS INC CO APLS | BIOGEN INC. BIIB | 18,469,475 14.200% | 18,469,475 (New Position) | Filing History |
| 2026-03-26 4:09 pm Sale | 2026-03-13 | 13G | BIOGEN INC BIIB | VANGUARD GROUP INC | 0 0.000% | -16,677,806 (Position Closed) | Filing History |
| 2026-02-05 1:16 pm Purchase | 2025-12-31 | 13G | BIOGEN INC BIIB | FMR LLC | 9,413,062 6.400% | 1,001,699 (+11.91%) | Filing History |
| 2025-11-13 8:28 pm Sale | 2025-09-30 | 13G | BIOGEN INC BIIB | PRIMECAP MANAGEMENT CO | 14,954,697 10.200% | -1,309,784 (-8.05%) | Filing History |
| 2025-11-10 08:15 am Sale | 2025-09-30 | 13G | BIOGEN INC BIIB | STATE STREET CORP STT | 7,321,168 5.000% | -25,337 (-0.34%) | Filing History |
| 2025-07-30 5:56 pm Sale | 2025-07-30 | 13D | SAGE THERAPEUTICS INC SAGE | BIOGEN INC. BIIB | 0 0.000% | -6,241,473 (Position Closed) | Filing History |
| 2025-07-21 9:18 pm Unchanged | 2025-07-21 | 13D | SAGE THERAPEUTICS INC SAGE | BIOGEN INC. BIIB | 6,241,473 10.000% | 0 (Unchanged) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | BIOGEN INC BIIB | BlackRock Inc. BLK | 12,506,681 8.500% | -2,140,070 (-14.61%) | Filing History |
| 2025-01-10 5:34 pm Unchanged | 2025-01-10 | 13D | SAGE THERAPEUTICS INC SAGE | BIOGEN INC. BIIB | 6,241,473 10.200% | 0 (Unchanged) | Filing History |
| 2024-11-12 1:24 pm Unchanged | 2024-09-30 | 13G | BIOGEN INC BIIB | VANGUARD GROUP INC | 16,677,806 11.440% | 0 (Unchanged) | Filing History |
| 2024-11-07 4:48 pm Sale | 2024-10-30 | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 7,155,243 4.970% | -5,596,122 (-43.89%) | Filing History |
| 2024-11-04 11:20 am Purchase | 2024-09-30 | 13G | BIOGEN INC BIIB | VANGUARD GROUP INC | 16,677,806 11.440% | 2,156,464 (+14.85%) | Filing History |
| 2024-10-16 12:11 pm Purchase | 2024-09-30 | 13G | BIOGEN INC BIIB | STATE STREET CORP STT | 7,346,505 5.000% | 7,346,505 (New Position) | Filing History |
| 2024-08-16 6:40 pm Sale | 2024-08-14 | 13G | SANGAMO THERAPEUTICS INC SGMO | BIOGEN INC. BIIB | 3,250,000 1.600% | -11,402,466 (-77.82%) | Filing History |
| 2024-08-07 4:10 pm Purchase | 2024-07-31 | 13G | BIOGEN INC BIIB | BlackRock Inc. BLK | 14,646,751 10.100% | 400,431 (+2.81%) | Filing History |
| 2024-02-12 7:11 pm Sale | 2023-12-31 | 13G | SANGAMO THERAPEUTICS INC SGMO | BIOGEN INC. BIIB | 14,652,466 8.260% | -9,767,691 (-40.00%) | Filing History |
| 2024-02-12 7:07 pm Sale | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 12,751,365 9.230% | -558,878 (-4.20%) | Filing History |
| 2024-02-12 4:01 pm Purchase | 2023-12-31 | 13G | BIOGEN INC BIIB | PRIMECAP MANAGEMENT CO | 16,264,481 11.220% | 563,905 (+3.59%) | Filing History |
| 2024-02-12 11:21 am Purchase | 2024-01-31 | 13G | BIOGEN INC BIIB | VANGUARD GROUP INC | 14,521,342 10.020% | 114,463 (+0.79%) | Filing History |